FdaApplication
BLA 761070
Identifiers
- fda_app_no: BLA761070
Properties
| Property | Value |
|---|---|
| applicant_name | AstraZeneca AB |
| application_type | BLA |
| approval_date | 2017-11-14 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| FASENRA | BENRALIZUMAB | 30MG/ML | Injection |
| FASENRA | — | 30MG/ML | Injection |
| FASENRA | — | 10MG/0.5ML | Injection |
3 products